Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411315 · ClinicalTrials.gov registry record · NA
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 700
- Enrollment target
NCT05411315: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05411315 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 700 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05411315, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
Study Summary
Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.
Primary Outcome
Number of days hospitalized in the medical intensive care unit
Interventions
- OTHER Restricted-use of arterial catheter
- OTHER Standard-use of arterial catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2023-07-14 |
| Phase | NA |
What the finished NCT05411315 record still lists
NCT05411315 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which Restricted-use of arterial catheter is the first listed.
NCT05411315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05411315 about?
NCT05411315 is a clinical study titled "Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment". Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.
What is the current status of trial NCT05411315?
This trial is currently completed. It is a NA study. The enrollment target is 700 participants. The study started on 2022-10-17. Estimated completion is 2023-07-14.
What interventions are being tested in trial NCT05411315?
The interventions under investigation include: Restricted-use of arterial catheter (OTHER), Standard-use of arterial catheter (OTHER).
Who is sponsoring clinical trial NCT05411315?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05411315's enrollment target sits among peer trials
700 149th of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI